Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats

Autonomic Neuroscience: Basic and Clinical

Volumn 159, Issue 1-2, 2011, Pages 38-44

  Botelho Ono, Mayumi S ^a   Pina, Hermano V ^a   Sousa, Karla H F ^a   Nunes, Fabiola C ^a   Medeiros, Isac A ^a   Braga, Valdir A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Antioxidants; Apocynin; Autonomic function; NADPH oxidase; Vitamin C

Indexed keywords

APOCYNIN; ASCORBIC ACID; METHYLATROPINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART INDEX; HEART RATE; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; HEART RATE; HYPERTENSION; KIDNEY DISEASES; MALE; RATS; RATS, WISTAR; SUPEROXIDES;

EID: 78649907748     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.07.025     Document Type: Article

References (42)

1. Accorsi-Mendonça D., Leão R.M., Aguiar J.F., Varanda W.A., Machado B.H. Urethane inhibits the GABAergic neurotransmission in the nucleus of the solitary tract of rat brain stem slices. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292(1):R396-R402.
2. Agus D.B., Gambhir S.S., Pardridge W.M., Spielholz C., Baselga J., Vera J.C., Golde D.W. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J. Clin. Invest. 1997, 100:2842-2848.
3. Berry C., Hamilton C.A., Brosnan M.J., Magill F.G., Berg G.A., McMurray J.J., Dominiczak A.F. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000, 101:2206-2212.
4. Braga V.A. Dietary salt enhances angiotensin II-induced superoxide formation in the rostral ventrolateral medulla. Auton. Neurosci. 2010, 155(1-2):14-18.
5. Braga V.A., Burmeister M.A., Zhou Y., Sharma R.V., Davisson R.L. Selective ablation of AT1a receptors in rostral ventrolateral medulla (RVLM) prevents chronic angiotensin-II-dependent hypertension in part by reducing oxidant stress in this region. Hypertension 2008, 52:e36.
6. Braga V.A., Burmeister M.A., Sharma R.V., Davisson R.L. Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295(4):R1168-R1174.
7. Chapleau M.W., Cunningham J.T., Sullivan M.J., Wachtel R.E., Abboud F.M. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995, 26(2):341-347.
8. Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001, 38:606-611.
9. Chowdhary S., Vaile J.C., Fletcher J., Ross H.F., Coote J.H., Townend J.N. Nitric oxide and cardiac autonomic control in humans. Hypertension 2000, 36:264-269.
10. Costa C.A., Amaral T.A., Carvalho L.C., Ognibene D.T., da Silva A.F., Moss M.B., Valença S.S., de Moura R.S., Resende A.C. Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. 2009, 22(12):1242-1249.
11. Gao S.A., Johansson M., Rundqvist B., Lambert G., Jensen G., Friberg P. Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. J. Hypertens. 2002, 20(1):111-116.
12. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998, 31:68-72.
13. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994, 74:1141-1148.
14. Guyenet P.G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 2006, 7:335-346.
15. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton. Neurosci. 2008, 142(1-2):20-24.
16. Hong H.J., Hsiao G., Cheng T.H., Yen M.H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001, 38:1044-1048.
17. Houston M.C. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog. Cardiovasc. Dis. 2005, 47:396-449.
18. Kimura H., Liu S., Yamada S., Uchida K., Matsumoto K., Mukaida M., Yoshida K. Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte mononuclear, phagocytic leukocyte, 13μm to 25μm in diameter, with an ovoid or kidney-shaped nucleus, and azurophilic cytoplasmic granules. NADPH oxidase in early endotoxemia. Free Radic. Res. 2005, 39:845-851.
19. Kitiyakara C., Wilcox C.S. Antioxidants for hypertension. Curr. Opin. Nephrol. Hypertens. 1998, 7:531-538.
20. Landmesser U., Cai H., Dikalov S., Mc-Cann L., Hwang J., Jo H., Holland S.M., Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515.
21. Landmesser U., Dikalov S., Price S.R., Mc-Cann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003, 111:1201-1209.
22. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R277-R297.
23. Li Z., Mao H.Z., Abboudm F.M., Chapleau M.W. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ. Res. 1996, 79:802-811.
24. Maliszewska-Scislo M., Chen H., Augustyniak R.A., Seth D., Rossi N.F. Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295(3):R741-R750.
25. Monahan K.D., Eskurza I., Seals D.R. Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men. Am. J. Physiol. Heart Circ. Physiol. 2004, 286(6):H2113-H2117.
26. Nightingale A.K., Blackman D.J., Field R., Glover N.J., Pegge N., Mumford C., Schmitt M., Ellis G.R., Morris-Thurgood J.A., Frenneaux M.P. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin. Sci. (Lond) 2003, 104:529-535.
27. Nishi E.E., Oliveira-Sales E.B., Bergamaschi C.T., Oliveira T.G., Boim M.A., Campos R.R. Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am. J. Hypertens. 2010, 23(5):473-480.
28. Oliveira-Sales E.B., Dugaich A.P., Carillo B.A., Abreu N.P., Boim M.A., Martins P.J., D'Almeida V., Dolnikoff M.S., Bergamaschi C.T., Campos R.R. Oxidative stress contributes to renovascular hypertension. Am. J. Hypertens. 2008, 21(1):98-104.
29. Oliveira-Sales E.B., Nishi E.E., Carillo B.A., Boim M.A., Dolnikoff M.S., Bergamaschi C.T., Campos R.R. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am. J. Hypertens. 2009, 22(5):484-492.
30. Piccirillo G., Nocco M., Moise A., Lionetti M., Naso C., di Carlo S., Marigliano V. Influence of vitamin C on baroreflex sensitivity in chronic heart failure. Hypertension 2003, 41:1240-1245.
31. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NAD(P)H oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 1996, 97:1916-1923.
32. Salgado M.C., Justo S.V., Joaquim L.F., Fazan R., Salgado H.C. Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting. Am. J. Physiol. Heart Circ. Physiol. 2006, 290(3):H1059-H1063.
33. Salgado H.C., Barale A.R., Castania J.A., Machado B.H., Chapleau M.W., Fazan R. Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H593-H600.
34. Sonta T., Inoguchi T., Tsubouchi H., Sekiguchi N., Kobayashi K., Matsumoto S., Utsumi H., Nawata H. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic. Biol. Med. 2004, 37:115-123.
35. Souza H.C., De Araújo J.E., Martins-Pinge M.C., Cozza I.C., Martins-Dias D.P. Nitric oxide synthesis blockade reduced the baroreflex sensitivity in trained rats. Auton. Neurosci. 2009, 150(1-2):38-44.
36. Spector R. Vitamin homeostasis in the central nervous system. N. Engl. J. Med. 1977, 296:1393-1398.
37. Spieker L.E., Corti R., Binggeli C., Luscher T.F., Noll G. Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans. J. Am. Coll. Cardiol. 2000, 36:213-218.
38. Sun M.K., Reis D.J. Urethane directly inhibits chemoreflex excitation of medullary vasomotor neurons in rats. Eur. J. Pharmacol. 1995, 293(3):237-243.
39. Touyz R.M., Schiffrin E.L. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J. Hypertens. 2001, 19:1245-1254.
40. Virdis A., Neves M.F., Amiri F., Touyz R.M., Schiffrin E.L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II infused mice. J. Hypertens. 2004, 22:535-542.
41. Zanzinger J., Czachurski J., Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1995, 268:R958-R962.
42. Zimmerman M.C., Lazartigues E., Sharma R.V., Davisson R.L. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 2004, 95(2):210-216.